Suppr超能文献

成年期孤立性垂体前叶功能减退症。

Isolated anterior pituitary dysfunction in adulthood.

机构信息

Department of Medical Science, Division of Endocrinology, Diabetes and Metabolism, University of Turin, Turin, Italy.

出版信息

Front Endocrinol (Lausanne). 2023 Mar 8;14:1100007. doi: 10.3389/fendo.2023.1100007. eCollection 2023.

Abstract

Hypopituitarism is defined as a complete or partial deficiency in one or more pituitary hormones. Anterior hypopituitarism includes secondary adrenal insufficiency, central hypothyroidism, hypogonadotropic hypogonadism, growth hormone deficiency and prolactin deficiency. Patients with hypopituitarism suffer from an increased disability and sick days, resulting in lower health status, higher cost of care and an increased mortality. In particular during adulthood, isolated pituitary deficits are not an uncommon finding; their clinical picture is represented by vague symptoms and unclear signs, which can be difficult to properly diagnose. This often becomes a challenge for the physician. Aim of this narrative review is to analyse, for each anterior pituitary deficit, the main related etiologies, the characteristic signs and symptoms, how to properly diagnose them (suggesting an easy and reproducible step-based approach), and eventually the treatment. In adulthood, the vast majority of isolated pituitary deficits are due to pituitary tumours, head trauma, pituitary surgery and brain radiotherapy. Immune-related dysfunctions represent a growing cause of isolated pituitary deficiencies, above all secondary to use of oncological drugs such as immune checkpoint inhibitors. The diagnosis of isolated pituitary deficiencies should be based on baseline hormonal assessments and/or dynamic tests. Establishing a proper diagnosis can be quite challenging: in fact, even if the diagnostic methods are becoming increasingly refined, a considerable proportion of isolated pituitary deficits still remains without a certain cause. While isolated ACTH and TSH deficiencies always require a prompt replacement treatment, gonadal replacement therapy requires a benefit-risk evaluation based on the presence of comorbidities, age and gender of the patient; finally, the need of growth hormone replacement therapies is still a matter of debate. On the other side, prolactin replacement therapy is still not available. In conclusion, our purpose is to offer a broad evaluation from causes to therapies of isolated anterior pituitary deficits in adulthood. This review will also include the evaluation of uncommon symptoms and main etiologies, the elements of suspicion of a genetic cause and protocols for diagnosis, follow-up and treatment.

摘要

垂体功能减退症定义为一种或多种垂体激素完全或部分缺乏。垂体前叶功能减退症包括继发性肾上腺皮质功能不全、中枢性甲状腺功能减退症、促性腺激素缺乏性性腺功能减退症、生长激素缺乏症和催乳素缺乏症。垂体功能减退症患者的残疾和病假天数增加,导致健康状况下降、护理费用增加和死亡率增加。特别是在成年期,孤立性垂体缺陷并不少见;其临床表现为模糊的症状和不明确的体征,难以正确诊断。这常常对医生构成挑战。本叙述性综述的目的是分析每种垂体前叶缺陷的主要相关病因、特征性症状和体征,如何正确诊断它们(建议采用简单且可重复的基于步骤的方法),最终是治疗方法。在成年期,绝大多数孤立性垂体缺陷是由于垂体瘤、头部外伤、垂体手术和脑部放疗引起的。免疫相关功能障碍是孤立性垂体缺乏的一个日益增加的原因,主要继发于使用免疫检查点抑制剂等抗肿瘤药物。孤立性垂体缺乏症的诊断应基于基线激素评估和/或动态试验。正确诊断可能具有挑战性:实际上,即使诊断方法越来越精细,相当一部分孤立性垂体缺乏症仍无法确定病因。虽然孤立性 ACTH 和 TSH 缺乏症始终需要进行及时的替代治疗,但性腺替代治疗需要根据患者的合并症、年龄和性别进行获益-风险评估;最后,生长激素替代治疗的需求仍存在争议。另一方面,还没有催乳素替代治疗。总之,我们的目的是从病因到成年期孤立性垂体前叶缺陷的治疗方法进行广泛评估。本综述还将包括对罕见症状和主要病因、遗传原因的可疑因素以及诊断、随访和治疗方案的评估。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/492f/10032221/399afda9ffd4/fendo-14-1100007-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验